BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 14967720)

  • 1. Protective effects of endogenous adrenomedullin on cardiac hypertrophy, fibrosis, and renal damage.
    Niu P; Shindo T; Iwata H; Iimuro S; Takeda N; Zhang Y; Ebihara A; Suematsu Y; Kangawa K; Hirata Y; Nagai R
    Circulation; 2004 Apr; 109(14):1789-94. PubMed ID: 14967720
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antifibrotic effect of adrenomedullin on coronary adventitia in angiotensin II-induced hypertensive rats.
    Tsuruda T; Kato J; Hatakeyama K; Masuyama H; Cao YN; Imamura T; Kitamura K; Asada Y; Eto T
    Cardiovasc Res; 2005 Mar; 65(4):921-9. PubMed ID: 15721873
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological inhibition and genetic deficiency of plasminogen activator inhibitor-1 attenuates angiotensin II/salt-induced aortic remodeling.
    Weisberg AD; Albornoz F; Griffin JP; Crandall DL; Elokdah H; Fogo AB; Vaughan DE; Brown NJ
    Arterioscler Thromb Vasc Biol; 2005 Feb; 25(2):365-71. PubMed ID: 15576638
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Angiotensin-converting enzyme 2 suppresses pathological hypertrophy, myocardial fibrosis, and cardiac dysfunction.
    Zhong J; Basu R; Guo D; Chow FL; Byrns S; Schuster M; Loibner H; Wang XH; Penninger JM; Kassiri Z; Oudit GY
    Circulation; 2010 Aug; 122(7):717-28, 18 p following 728. PubMed ID: 20679547
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibitory effect of antisense oligodeoxynucleotide to p44/p42 MAPK on angiotensin II-induced hypertrophic response in cultured neonatal rat cardiac myocyte.
    Zhang SQ; Ding B; Guo ZG; Li YX
    Acta Pharmacol Sin; 2004 Jan; 25(1):41-6. PubMed ID: 14704121
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deletion of the inducible 70-kDa heat shock protein genes in mice impairs cardiac contractile function and calcium handling associated with hypertrophy.
    Kim YK; Suarez J; Hu Y; McDonough PM; Boer C; Dix DJ; Dillmann WH
    Circulation; 2006 Jun; 113(22):2589-97. PubMed ID: 16735677
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pitavastatin, an HMG-CoA reductase inhibitor, exerts eNOS-independent protective actions against angiotensin II induced cardiovascular remodeling and renal insufficiency.
    Yagi S; Aihara K; Ikeda Y; Sumitomo Y; Yoshida S; Ise T; Iwase T; Ishikawa K; Azuma H; Akaike M; Matsumoto T
    Circ Res; 2008 Jan; 102(1):68-76. PubMed ID: 17967781
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeted disruption of Smad4 in cardiomyocytes results in cardiac hypertrophy and heart failure.
    Wang J; Xu N; Feng X; Hou N; Zhang J; Cheng X; Chen Y; Zhang Y; Yang X
    Circ Res; 2005 Oct; 97(8):821-8. PubMed ID: 16151019
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Guanylyl cyclase-A inhibits angiotensin II type 1A receptor-mediated cardiac remodeling, an endogenous protective mechanism in the heart.
    Li Y; Kishimoto I; Saito Y; Harada M; Kuwahara K; Izumi T; Takahashi N; Kawakami R; Tanimoto K; Nakagawa Y; Nakanishi M; Adachi Y; Garbers DL; Fukamizu A; Nakao K
    Circulation; 2002 Sep; 106(13):1722-8. PubMed ID: 12270869
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endothelin-1-induced cardiac hypertrophy is inhibited by activation of peroxisome proliferator-activated receptor-alpha partly via blockade of c-Jun NH2-terminal kinase pathway.
    Irukayama-Tomobe Y; Miyauchi T; Sakai S; Kasuya Y; Ogata T; Takanashi M; Iemitsu M; Sudo T; Goto K; Yamaguchi I
    Circulation; 2004 Feb; 109(7):904-10. PubMed ID: 14967736
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Calcineurin-nuclear factor of activated T cells pathway-dependent cardiac remodeling in mice deficient in guanylyl cyclase A, a receptor for atrial and brain natriuretic peptides.
    Tokudome T; Horio T; Kishimoto I; Soeki T; Mori K; Kawano Y; Kohno M; Garbers DL; Nakao K; Kangawa K
    Circulation; 2005 Jun; 111(23):3095-104. PubMed ID: 15939815
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Celiprolol, a vasodilatory beta-blocker, inhibits pressure overload-induced cardiac hypertrophy and prevents the transition to heart failure via nitric oxide-dependent mechanisms in mice.
    Liao Y; Asakura M; Takashima S; Ogai A; Asano Y; Shintani Y; Minamino T; Asanuma H; Sanada S; Kim J; Kitamura S; Tomoike H; Hori M; Kitakaze M
    Circulation; 2004 Aug; 110(6):692-9. PubMed ID: 15262839
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Small heat-shock protein Hsp20 attenuates beta-agonist-mediated cardiac remodeling through apoptosis signal-regulating kinase 1.
    Fan GC; Yuan Q; Song G; Wang Y; Chen G; Qian J; Zhou X; Lee YJ; Ashraf M; Kranias EG
    Circ Res; 2006 Nov; 99(11):1233-42. PubMed ID: 17068291
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Osteopontin modulates angiotensin II-induced fibrosis in the intact murine heart.
    Collins AR; Schnee J; Wang W; Kim S; Fishbein MC; Bruemmer D; Law RE; Nicholas S; Ross RS; Hsueh WA
    J Am Coll Cardiol; 2004 May; 43(9):1698-705. PubMed ID: 15120833
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protective effects of statin on cardiac fibrosis and apoptosis in adrenomedullin-knockout mice treated with angiotensin II and high salt loading.
    Yamamoto C; Fukuda N; Jumabay M; Saito K; Matsumoto T; Ueno T; Soma M; Matsumoto K; Shimosawa T
    Hypertens Res; 2011 Mar; 34(3):348-53. PubMed ID: 21160482
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adiponectin protects against angiotensin II-induced cardiac fibrosis through activation of PPAR-alpha.
    Fujita K; Maeda N; Sonoda M; Ohashi K; Hibuse T; Nishizawa H; Nishida M; Hiuge A; Kurata A; Kihara S; Shimomura I; Funahashi T
    Arterioscler Thromb Vasc Biol; 2008 May; 28(5):863-70. PubMed ID: 18309113
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased collagen deposition and diastolic dysfunction but preserved myocardial hypertrophy after pressure overload in mice lacking PKCepsilon.
    Klein G; Schaefer A; Hilfiker-Kleiner D; Oppermann D; Shukla P; Quint A; Podewski E; Hilfiker A; Schröder F; Leitges M; Drexler H
    Circ Res; 2005 Apr; 96(7):748-55. PubMed ID: 15761199
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brain natriuretic peptide appears to act locally as an antifibrotic factor in the heart.
    Ogawa Y; Tamura N; Chusho H; Nakao K
    Can J Physiol Pharmacol; 2001 Aug; 79(8):723-9. PubMed ID: 11558681
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cellular physiology of rat cardiac myocytes in cardiac fibrosis: in vitro simulation using the cardiac myocyte/cardiac non-myocyte co-culture system.
    Ikeda K; Tojo K; Udagawa T; Otsubo C; Ishikawa M; Tokudome G; Hosoya T; Tajima N; Nakao K; Kawamura M
    Hypertens Res; 2008 Apr; 31(4):693-706. PubMed ID: 18633182
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Opposing roles of p47phox in basal versus angiotensin II-stimulated alterations in vascular O2- production, vascular tone, and mitogen-activated protein kinase activation.
    Li JM; Wheatcroft S; Fan LM; Kearney MT; Shah AM
    Circulation; 2004 Mar; 109(10):1307-13. PubMed ID: 14993144
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.